Data sovereignty key navigating 340B's future helps healthcare leaders build integrated data systems for compliance and financial resilience in 2026.

The Patient Protection and Affordable Care Act is expected to bring significant change to the healthcare industry, including the expansion of the Public Health Service Act Section 340B Program.

Since 1992, the 340B drug discount program has entitled certain federal grantee clinics and hospitals (called “covered entities”) to purchase outpatient drugs at substantial discounts. The discounted ...

The rapid expansion of the federal 340B drug pricing program is significantly affecting Medicaid budgets, particularly in states where managed care plans oversee prescription drug benefits. New ...

The Trump administration's attempt to overhaul how safety net hospitals pay for outpatient drugs has run into a major legal wall, with a federal appeals court keeping a freeze on a controversial pilot ...

Seven hospital associations representing more than 2,000 hospitals have sent a letter to the Health Resources and Services Administration, asking the Trump administration for an extended timeline for ...

Drug companies are at it again. They will not relent in their multiyear campaign to dismantle the 340B Drug Pricing Program. Drug companies are at it again. They will not relent in their multiyear ...

The Kansas Legislature is currently considering a bill, SB 284, under seemingly noble pretense. Proponents of SB 284 argue that its 340B provisions are needed to support rural hospitals and their ...

The 340B Drug Pricing Program was designed to help safety net providers serve low-income patients, but it has since ballooned into a multibillion-dollar system dominated by large health systems — with ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. In Maine, the 340B drug program was meant to be a structure of care — a ...